Studies of the aggregation of RNase Sa
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Studies of the aggregation of RNase Sa. / Khasa, Harshit; Kramer, Ryan; Maddux, Nathan; Hamborg, Mette ; Joshi, Sangeeta B; Volkin, David B; Middaugh, C Russell.
In: Journal of Pharmaceutical Sciences, Vol. 103, No. 2, 02.2014, p. 395-9.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Studies of the aggregation of RNase Sa
AU - Khasa, Harshit
AU - Kramer, Ryan
AU - Maddux, Nathan
AU - Hamborg, Mette
AU - Joshi, Sangeeta B
AU - Volkin, David B
AU - Middaugh, C Russell
N1 - © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association.
PY - 2014/2
Y1 - 2014/2
N2 - Thirty-eight mutants of RNase Sa (ribonuclease from Streptomyces aureofaciens) were examined for their structure, thermal sensitivity, and tendency to aggregate. Although a biphasic correlation was seen between the effect of temperature on structure and the free energy of transfer changes in many of the mutants, little correlation was seen between the time at which aggregation is initiated or the rate of aggregation and the thermal sensitivity of the mutants. It is hypothesized that the nature of contacts between protein molecules in the associated (aggregated) phase rather than structural changes dominates the aggregation process for these series of mutants.
AB - Thirty-eight mutants of RNase Sa (ribonuclease from Streptomyces aureofaciens) were examined for their structure, thermal sensitivity, and tendency to aggregate. Although a biphasic correlation was seen between the effect of temperature on structure and the free energy of transfer changes in many of the mutants, little correlation was seen between the time at which aggregation is initiated or the rate of aggregation and the thermal sensitivity of the mutants. It is hypothesized that the nature of contacts between protein molecules in the associated (aggregated) phase rather than structural changes dominates the aggregation process for these series of mutants.
U2 - 10.1002/jps.23841
DO - 10.1002/jps.23841
M3 - Journal article
C2 - 24382748
VL - 103
SP - 395
EP - 399
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
SN - 0022-3549
IS - 2
ER -
ID: 111431498